Home  >  News
Diagnostics
+ Font Resize -

POC Medical Systems collaborates with Ushalakshmi Breast Cancer Foundation

Our Bureau, Mumbai
Monday, June 19, 2017, 17:50 Hrs  [IST]

POC Medical Systems Inc based out of California, which has innovated MammoAlert System - World’s first disruptive screening technology for breast cancer and Ushalakshmi Breast Cancer Foundation, a not for profit breast cancer charity based out of Hyderabad has announced collaboration to launch Pan India multi centre breast cancer screening trial based upon disruptive technology MammoAlert – a rapid, low cost, accurate blood test’.

Dr. P. Raghu Ram, CEO Ushalakshmi Breast Cancer Foundation and Director, KIMS-USHALAKSHMI Centre for Breast Diseases will be spearheading this Clinical Trial as Pan India Principal Investigator.The study design involves looking at activity of panel of four Breast cancer specific biomarkers in a blood sample collected from women presenting with newly diagnosed breast cancers to seven Cancer Centres spread across India. KIMS-Hospitals and Indo American Cancer Centre from Hyderabad, Manipal Hospitals (Bengaluru), Tata Medical Centre (Kolkata), Maulana Azad Medical College (New Delhi), Amrita Institute of Medical Sciences (Kochi) and HCG Cancer Centre (Ahmedabad) would be participating in this landmark Study to assess the accuracy of this blood test.

Since beginning of June 2017, more than 100 patients have already been recruited in this trial. The clinical study will help POC Medical Systems Inc. to revalidate the technology in Indian patients and get accurate India centric data. This data exercise would also be a stepping stone towards designing and implementing a population based Breast Cancer Screening programme in the rural areas all across India in collaboration with Ushalakshmi Breast Cancer Foundation.

Sanjeev Saxena, Managing Director, POC Medical Systems Inc, California, USA said, “We are very excited to collaborate with Ushalakshmi Breast Cancer Foundation as our vision is same, i.e. Early detection of Breast Cancer’. This collaboration would help spread the message about importance of early detection and offer a simple cost effective reliable screening tool in the form of a blood test to underprivileged women living in rural India.”

While speaking at the Press Conference, Ramana Tadepalli, Board Director, POC Medical Systems Inc. mentioned, “It’s a very proud moment as we have recently received the CE Certification (legal designation that the manufacturer's product has met the requirements of all relevant Medical Device Directives in the European Union). We are delighted that Dr. Raghu Ram, one of the foremost Breast Surgeons from South Asia is the Principal Investigator (PI) spearheading the Multi Centre Pan India Clinical trial to assess the accuracy of MammoAlert-  a rapid, low cost, accurate blood test to detect early breast cancer. We are confident of achieving our end goals i.e. erasing fear of cancer, as early detection ensures better cure rates”.

Dr. P. Raghu Ram, Padma Shri awardee, CEO, Ushalakshmi Breast Cancer Foundation based out of Hyderabad said, “The Foundation’s vision for the next ten years is to replicate the impact created in the Telugu States all across the Country. We are very happy to associate with POC Medical Systems and its flagship product MammoAlert.”

This portable breast cancer screening test uses a simple drop of blood to generate results in 15 minutes. It does not require expensive equipment or expertise to generate the result. In the Studies done thus far, the MammoAlert’ has demonstrated an accuracy of over 95% and a false positive rate of zero. This disruptive technology will hopefully have a huge social impact enabling thousands of women in India to detect breast cancer in its early stage as this test is simple, low cost and accurate.

POC Medical Systems Inc. is a California based company founded in May 2013 by Sanjeev Saxena and his team of well experienced technology and biomedical professionals, with a patent-protected, path breaking Point of Care testing product for Breast Cancer.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
IPJPI_150x60en_2017
CPhI-WWW-150x60-stat-v1
IPJPI_150x60en_2017
chemspec2017
cphikorea_150x60_k
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |